BOROUGE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.46 AED | 0.00% |
|
-0.40% | -0.40% |
| Apr. 30 | Borouge Posts Higher Q1 Attributable Profit; Revenue Down | MT |
| Apr. 30 | Borouge plc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company is one of the best yield companies with high dividend expectations.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an enterprise value anticipated at 13.42 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Specialty Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.40% | 20.13B | - | ||
| +7.30% | 4.14B | B | ||
| +11.34% | 1.46B | B | ||
| -7.84% | 1.13B | B- | ||
| +23.50% | 992M | - | ||
| -5.00% | 755M | - | - | |
| -20.11% | 713M | - | ||
| -9.36% | 306M | - | - | |
| -6.98% | 270M | - | - | |
| -1.71% | 263M | D- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- BOROUGE Stock
- Ratings Borouge plc